[212] K. Johe, T. Hazel, T. Muller, M. Dugich-Djordjevic, and R. McKay. Single factors direct the differentiation <strong>of</strong> stem cells from the fetal and adult central nervous system. Genes & development, 10(24):3129, 1996. [213] B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks. Human MicroRNA targets. PLoS Biol, 2(11):e363, 2004. [214] P. Jones and P. Laird. Cancer-epigenetics comes <strong>of</strong> age. Nature genetics, 21(2):163– 167, 1999. [215] A. Kanawaty and J. Henderson. Genomic analysis <strong>of</strong> induced pluripotent stem (ips) cells: routes to reprogramming. Bioessays, 31(2):134–138, 2009. [216] Y. Kang, I. Kim, E. Kim, M. Yoon, S. Kim, T. Kwon, and K. Choi. Paxilline enhances trail-mediated apoptosis <strong>of</strong> glioma cells via modulation <strong>of</strong> c-flip, survivin and dr5. Experimental & molecular medicine, 43(1):24, 2011. [217] Y. Kang, I. Kim, E. Kim, M. Yoon, S. Kim, T. Kwon, and K. Choi. Paxilline enhances trail-mediated apoptosis <strong>of</strong> glioma cells via modulation <strong>of</strong> c-flip, survivin and dr5. Experimental & molecular medicine, 43(1):24–34, 2011. [218] A. Kaul and W. Maltese. Killing <strong>of</strong> cancer cells by the photoactivatable protein kinase c inhibitor, calphostin c, involves induction <strong>of</strong> endoplasmic reticulum stress. Neoplasia (New York, NY), 11(9):823, 2009. [219] B. Kaur, F. Khwaja, E. Severson, S. Matheny, D. Brat, and E. Van Meir. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neurooncology, 7(2):134, 2005. [220] M. Kawashima, K. Doh-ura, E. Mekada, M. Fukui, and T. Iwaki. Cd9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors. Journal <strong>of</strong> Histochemistry & Cytochemistry, 50(9):1195, 2002. [221] M. Kawashima, K. Doh-ura, E. Mekada, M. Fukui, and T. Iwaki. Cd9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors. Journal <strong>of</strong> Histochemistry & Cytochemistry, 50(9):1195–1203, 2002. [222] M. Kedde, M. J. Strasser, B. Boldajipour, J. A. Oude Vrielink, K. Slanchev, C. le Sage, R. Nagel, P. M. Voorhoeve, J. van Duijse, U. A. Orom, A. H. Lund, A. Perrakis, E. Raz, and R. Agami. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell, 131(7):1273–86, 2007. [223] G. Kempermann, S. Jessberger, B. Steiner, and G. Kronenberg. Milestones <strong>of</strong> neuronal development in the adult hippocampus. Trends in Neurosciences, 27(8):447–452, 2004. [224] M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul, and E. Segal. The role <strong>of</strong> site accessibility in microrna target recognition. Nature genetics, 39(10):1278–1284, 2007. [225] I. Kil, S. Kim, S. Lee, and J. Park. Small interfering RNA-mediated silencing <strong>of</strong> mitochondrial NADP + -dependent isocitrate dehydrogenase enhances the sensitivity <strong>of</strong> HeLa cells toward tumor necrosis factor-α and anticancer drugs. Free Radical Biology and Medicine, 43(8):1197–1207, 2007. [226] D. Kim, C. H. Kim, J. I. Moon, Y. G. Chung, M. Y. Chang, B. S. Han, S. Ko, E. Yang, K. Y. Cha, R. Lanza, and K. S. Kim. Generation <strong>of</strong> human induced pluripotent stem cells by direct delivery <strong>of</strong> reprogramming proteins. Cell <strong>Stem</strong> Cell, 4(6):472–6, 2009. [227] I. Kim, Y. Kang, M. Yoon, E. Kim, S. Kim, T. Kwon, I. Kim, and K. Choi. Amiodarone sensitizes human glioma cells but not astrocytes to trail-induced apoptosis via chopmediated dr5 upregulation. Neuro-oncology, 13(3):267–279, 2011. [228] J. Kim, J. Choi, S. Lim, O. Kwon, J. Seo, S. Ryu, and P. Suh. Phospholipase c-eta 1 is activated by intracellular ca2+ mobilization and enhances gpcrs/plc/ca2+ signaling. Cellular Signalling, 2011. [229] S. Kim, M. Seong, B. Jeon, H. Ko, J. Kim, and S. Park. Phase analysis identifies compound heterozygous deletions <strong>of</strong> the PARK2 gene in patients with early-onset Parkinson disease. Clinical Genetics. [230] T. Kim, M. Hemberg, J. Gray, A. Costa, D. Bear, J. Wu, D. Harmin, M. Laptewicz, K. Barbara-Haley, S. Kuersten, et al. Widespread transcription at neuronal activityregulated enhancers. Nature, 465(7295):182–187, 2010.
[231] T.-M. Kim, W. Huang, R. Park, P. J. Park, and M. D. Johnson. A developmental taxonomy <strong>of</strong> glioblastoma defined and maintained by MicroRNAs. Cancer Research, 71(9):3387–3399, May 2011. [232] V. N. Kim. MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology, 6(5):376–385, May 2005. [233] W. Kim and N. Sharpless. The regulation <strong>of</strong> INK4/ARF in cancer and aging. Cell, 127(2):265–275, 2006. [234] R. Kincaid, A. Kuchinsky, and M. Creech. Vistaclara: an expression browser plug-in for cytoscape. Bioinformatics, 24(18):2112–2114, 2008. [235] S. Kinney, D. Smiraglia, S. James, M. Moser, B. Foster, and A. Karpf. Stage-specific alterations <strong>of</strong> dna methyltransferase expression, dna hypermethylation, and dna hypomethylation during prostate cancer progression in the transgenic adenocarcinoma <strong>of</strong> mouse prostate model. Molecular Cancer Research, 6(8):1365–1374, 2008. [236] L. S. Kinsey M, Smith R. Nr0b1 is required for the oncogenic phenotype mediated by ews/fli in ewing’s sarcoma. Mol Cancer Res, 4:851–859, 2006. [237] M. Kiriakidou, P. T. Nelson, A. Kouranov, P. Fitziev, C. Bouyioukos, Z. Mourelatos, and A. Hatzigeorgiou. A combined computational-experimental approach predicts human microRNA targets. Genes Dev, 18(10):1165–78, 2004. [238] M. Kitano, M. Nakaya, T. Nakamura, S. Nagata, and M. Matsuda. Imaging <strong>of</strong> rab5 activity identifies essential regulators for phagosome maturation. Nature, 453(7192):241– 245, 2008. [239] C. Klattenh<strong>of</strong>f and W. Theurkauf. Biogenesis and germline functions <strong>of</strong> piRNAs. Development, 135(1):3–9, 2008. [240] A. Klein and B. Simons. Universal patterns <strong>of</strong> stem cell fate in cycling adult tissues. Development, 138(15):3103, 2011. [241] T. Kolesnikova, A. Kazarov, M. Lemieux, M. Lafleur, S. Kesari, A. Kung, and M. Hemler. Glioblastoma inhibition by cell surface immunoglobulin protein ewi-2, in vitro and in vivo. Neoplasia (New York, NY), 11(1):77, 2009. [242] T. Kondo, T. Setoguchi, and T. Taga. Persistence <strong>of</strong> a small subpopulation <strong>of</strong> cancer stem-like cells in the c6 glioma cell line. Proceedings <strong>of</strong> the National Academy <strong>of</strong> Sciences <strong>of</strong> the United States <strong>of</strong> America, 101(3):781, 2004. [243] K. Kondoh, N. Tsuji, C. Kamagata, M. Sasaki, D. Kobayashi, A. Yagihashi, and N. Watanabe. A novel aspartic protease gene, alp56, is up-regulated in human breast cancer independently from the cathepsin d gene. Breast cancer research and treatment, 78(1):37–44, 2003. [244] A. Korshunov, R. Sycheva, and A. Golanov. Genetically distinct and clinically relevant subtypes <strong>of</strong> glioblastoma defined by array-based comparative genomic hybridization (array-cgh). Acta neuropathologica, 111(5):465–474, 2006. [245] D. Koul, R. Shen, S. Bergh, Y. Lu, J. de Groot, T. Liu, G. Mills, and W. Yung. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression <strong>of</strong> human glioblastoma. Molecular cancer therapeutics, 4(11):1681, 2005. [246] C. R. E. C. B. M. C. D. Kourtidis A, Jain R. An rna interference screen identifies metabolic regulators nr1d1 and pbp as novel survival factors for breast cancer cells with the erbb2 signature. Cancer Res, 70:1783–1792, 2010. [247] A. Krek, D. Grün, M. Poy, R. Wolf, L. Rosenberg, E. Epstein, P. MacMenamin, I. Da Piedade, K. Gunsalus, M. St<strong>of</strong>fel, et al. Combinatorial microrna target predictions. Nature genetics, 37(5):495–500, 2005. [248] A. Kriegstein and A. Alvarez-Buylla. The glial nature <strong>of</strong> embryonic and adult neural stem cells. Annual review <strong>of</strong> neuroscience, 32:149, 2009. [249] A. Kriegstein and M. Götz. Radial glia diversity: a matter <strong>of</strong> cell fate. Glia, 43(1):37– 43, 2003. [250] R. Kroes, G. Dawson, and J. Moskal. Focused microarray analysis <strong>of</strong> glyco-gene expression in human glioblastomas. Journal <strong>of</strong> neurochemistry, 103(s1):14–24, 2007.
- Page 1 and 2:
Transcriptional Characterization of
- Page 3 and 4:
This dissertation is my own work an
- Page 5 and 6:
Acknowledgements I would like to th
- Page 7 and 8:
5.9 External Dataset Expression Cor
- Page 9 and 10:
Introduction 1
- Page 11 and 12:
1.1 Glial Cells in the Central Nerv
- Page 13 and 14:
1.2 Glioblastoma Multiforme Introdu
- Page 15 and 16:
1.2 Glioblastoma Multiforme Introdu
- Page 17 and 18:
1.2 Glioblastoma Multiforme Introdu
- Page 19 and 20:
1.3 Primary and Secondary Glioblast
- Page 21 and 22:
1.3 Primary and Secondary Glioblast
- Page 23 and 24:
1.3 Primary and Secondary Glioblast
- Page 25 and 26:
1.3 Primary and Secondary Glioblast
- Page 27 and 28:
1.3 Primary and Secondary Glioblast
- Page 29 and 30:
1.4 Pathways Involved in Glioblasto
- Page 31 and 32:
1.4 Pathways Involved in Glioblasto
- Page 33 and 34:
1.4 Pathways Involved in Glioblasto
- Page 35 and 36:
1.4 Pathways Involved in Glioblasto
- Page 37 and 38:
1.4 Pathways Involved in Glioblasto
- Page 39 and 40:
1.5 Pathway Crosstalk Introduction
- Page 41 and 42:
Chapter 2 Neurogenesis Contents 2.1
- Page 43 and 44:
2.1 Radial Glia Introduction VZ adj
- Page 45 and 46:
2.2 Neural Stem Cells Introduction
- Page 47 and 48:
2.2 Neural Stem Cells Introduction
- Page 49 and 50:
2.2 Neural Stem Cells Introduction
- Page 51 and 52:
2.2 Neural Stem Cells Introduction
- Page 53 and 54:
2.2 Neural Stem Cells Introduction
- Page 55 and 56:
2.2 Neural Stem Cells Introduction
- Page 57 and 58:
2.2 Neural Stem Cells Introduction
- Page 59 and 60:
2.2 Neural Stem Cells Introduction
- Page 61 and 62:
2.2 Neural Stem Cells Introduction
- Page 63 and 64:
2.2 Neural Stem Cells Introduction
- Page 65 and 66:
Chapter 3 Brain Cancer Stem Cells C
- Page 67 and 68:
3.1 The Cancer Stem Cell Hypothesis
- Page 69 and 70:
3.1 The Cancer Stem Cell Hypothesis
- Page 71 and 72:
3.2 Brain Cancer Stem Cells Introdu
- Page 73 and 74:
3.2 Brain Cancer Stem Cells Introdu
- Page 75 and 76:
3.2 Brain Cancer Stem Cells Introdu
- Page 77 and 78:
3.2 Brain Cancer Stem Cells Introdu
- Page 79 and 80:
3.2 Brain Cancer Stem Cells Introdu
- Page 81 and 82:
3.3 Glioma Culture Systems Introduc
- Page 83 and 84:
3.3 Glioma Culture Systems Introduc
- Page 85 and 86:
3.3 Glioma Culture Systems Introduc
- Page 87 and 88:
3.3 Glioma Culture Systems Introduc
- Page 89 and 90:
3.3 Glioma Culture Systems Introduc
- Page 91 and 92:
3.3 Glioma Culture Systems Introduc
- Page 93 and 94:
Chapter 4 The Non-Coding RNA World
- Page 95 and 96:
4.1 MicroRNA regulation Introductio
- Page 97 and 98:
4.1 MicroRNA regulation Introductio
- Page 99 and 100:
4.2 Target Prediction and Validatio
- Page 101 and 102:
Methods 93
- Page 103 and 104:
5.1 Tag-sequencing Data Processing
- Page 105 and 106:
5.1 Tag-sequencing Data Processing
- Page 107 and 108:
5.2 Array Comparative Genomic Hybri
- Page 109 and 110:
5.4 Quantitative Real Time-PCR Vali
- Page 111 and 112:
5.4 Quantitative Real Time-PCR Vali
- Page 113 and 114:
5.4 Quantitative Real Time-PCR Vali
- Page 115 and 116:
5.5 Literature Mining Methods Figur
- Page 117 and 118:
5.5 Literature Mining Methods How m
- Page 119 and 120:
5.6 Differential Isoform Expression
- Page 121 and 122:
5.9 External Dataset Expression Cor
- Page 123 and 124:
5.10 Glioblastoma Pathway Construct
- Page 125 and 126:
5.11 MicroRNA Target Prediction Ana
- Page 127 and 128:
Results 119
- Page 129 and 130:
6.2 Tag mapping Results Table 6.1:
- Page 131 and 132:
6.2 Tag mapping Results 123 Figure
- Page 133 and 134:
6.3 Copy Number Aberrations Results
- Page 135 and 136:
6.3 Copy Number Aberrations Results
- Page 137 and 138:
6.4 Core Differentially Expressed G
- Page 139 and 140:
6.4 Core Differentially Expressed G
- Page 141 and 142:
6.4 Core Differentially Expressed G
- Page 143 and 144:
6.4 Core Differentially Expressed G
- Page 145 and 146:
6.5 Large-scale qRT-PCR Validation
- Page 147 and 148:
6.5 Large-scale qRT-PCR Validation
- Page 149 and 150:
6.5 Large-scale qRT-PCR Validation
- Page 151 and 152:
6.6 Literature Mining for Different
- Page 153 and 154:
6.7 Isoform Differential Expression
- Page 155 and 156:
6.7 Isoform Differential Expression
- Page 157 and 158:
6.7 Isoform Differential Expression
- Page 159 and 160:
6.7 Isoform Differential Expression
- Page 161 and 162:
6.7 Isoform Differential Expression
- Page 163 and 164:
6.7 Isoform Differential Expression
- Page 165 and 166:
6.8 Long ncRNA Differential Express
- Page 167 and 168:
6.8 Long ncRNA Differential Express
- Page 169 and 170:
Chapter 7 Dataset Correlation Analy
- Page 171 and 172:
7.1 Enrichment Analysis Results Tab
- Page 173 and 174:
7.1 Enrichment Analysis Results Fig
- Page 175 and 176:
7.1 Enrichment Analysis Results Tab
- Page 177 and 178:
7.2 Glioblastoma Expression Signatu
- Page 179 and 180:
7.3 Tumour Expression Correlation R
- Page 181 and 182:
7.3 Tumour Expression Correlation R
- Page 183 and 184:
7.3 Tumour Expression Correlation R
- Page 185 and 186:
7.3 Tumour Expression Correlation R
- Page 187 and 188:
7.3 Tumour Expression Correlation R
- Page 189 and 190:
7.3 Tumour Expression Correlation R
- Page 191 and 192:
7.4 Survival Analysis Results Table
- Page 193 and 194:
7.4 Survival Analysis Results 867 g
- Page 195 and 196:
7.5 Glioblastoma Pathway Analysis R
- Page 197 and 198:
7.5 Glioblastoma Pathway Analysis R
- Page 199 and 200:
7.5 Glioblastoma Pathway Analysis R
- Page 201 and 202:
7.5 Glioblastoma Pathway Analysis R
- Page 203 and 204:
7.5 Glioblastoma Pathway Analysis R
- Page 205 and 206:
7.5 Glioblastoma Pathway Analysis R
- Page 207 and 208:
7.5 Glioblastoma Pathway Analysis R
- Page 209 and 210:
7.5 Glioblastoma Pathway Analysis R
- Page 211 and 212:
8.1 Principles Results say, this is
- Page 213 and 214:
8.3 Databases Results Figure 8.1: O
- Page 215 and 216:
8.3 Databases Results Figure 8.3: W
- Page 217 and 218:
8.4 Filters Results Bayesian method
- Page 219 and 220:
8.5 Target Prediction Ensemble Anal
- Page 221 and 222:
8.5 Target Prediction Ensemble Anal
- Page 223 and 224:
8.5 Target Prediction Ensemble Anal
- Page 225 and 226:
8.5 Target Prediction Ensemble Anal
- Page 227 and 228:
8.5 Target Prediction Ensemble Anal
- Page 229 and 230:
9.1. Digital Profiling of GNS Cell
- Page 231 and 232:
9.1. Digital Profiling of GNS Cell
- Page 233 and 234:
9.1. Digital Profiling of GNS Cell
- Page 235 and 236:
9.1. Digital Profiling of GNS Cell
- Page 237 and 238:
9.1. Digital Profiling of GNS Cell
- Page 239 and 240:
9.2. MicroRNA Target Prediction Ana
- Page 241 and 242:
9.3. Concluding Remarks Appendix pr
- Page 243 and 244:
A.1 Differential Expression Appendi
- Page 245 and 246:
A.1 Differential Expression Appendi
- Page 247 and 248:
A.1 Differential Expression Appendi
- Page 249 and 250:
A.1 Differential Expression Appendi
- Page 251 and 252:
A.1 Differential Expression Appendi
- Page 253 and 254:
A.1 Differential Expression Appendi
- Page 255 and 256:
A.1 Differential Expression Appendi
- Page 257 and 258:
A.1 Differential Expression Appendi
- Page 259 and 260:
A.2 Classified Differential Express
- Page 261 and 262:
A.2 Classified Differential Express
- Page 263 and 264:
A.2 Classified Differential Express
- Page 265 and 266:
A.3 Quantitative RT-PCR Appendix Ta
- Page 267 and 268:
A.3 Quantitative RT-PCR Appendix We
- Page 269 and 270:
A.3 Quantitative RT-PCR Appendix Ta
- Page 271 and 272:
A.3 Quantitative RT-PCR Appendix We
- Page 273 and 274:
A.4 Tag-seq vs qRT-PCR Correlation
- Page 275 and 276:
Appendix "BEX5", "DIAPH2", "GBP3",
- Page 277 and 278:
End Select End If End Sub Appendix
- Page 279 and 280:
If NameStr.ToLower().Equals("query"
- Page 281 and 282:
Appendix C Long ncRNAs We detected
- Page 283 and 284: C. Long ncRNAs Appendix Tag Accessi
- Page 285 and 286: D.1 Pathway Interactions Appendix F
- Page 287 and 288: D.1 Pathway Interactions Appendix F
- Page 289 and 290: D.1 Pathway Interactions Appendix F
- Page 291 and 292: D.2 Pathway Images Appendix Figure
- Page 293 and 294: D.2 Pathway Images Appendix Figure
- Page 295 and 296: E. Exon Array Data Appendix Average
- Page 297 and 298: E. Exon Array Data Appendix Average
- Page 299 and 300: E. Exon Array Data Appendix Average
- Page 301 and 302: E. Exon Array Data Appendix Average
- Page 303 and 304: E. Exon Array Data Appendix Average
- Page 305 and 306: E. Exon Array Data Appendix Average
- Page 307 and 308: E. Exon Array Data Appendix Average
- Page 309 and 310: F. MicroRNA Array Data Appendix Tab
- Page 311 and 312: F. MicroRNA Array Data Appendix GNS
- Page 313 and 314: F. MicroRNA Array Data Appendix GNS
- Page 315 and 316: Ln Natural logarithm LOH Loss of He
- Page 317 and 318: 3.3 Schematisation of cell cycle ph
- Page 319 and 320: 8.3 Workflows at the core of the pr
- Page 321 and 322: 7.1 Selected Gene Ontology terms an
- Page 323 and 324: Bibliography [1] Cell signaling tec
- Page 325 and 326: [38] G. Bain, D. Kitchens, M. Yao,
- Page 327 and 328: [78] S. Bustin, V. Benes, J. Garson
- Page 329 and 330: [112] M. Czystowska, J. Han, M. Szc
- Page 331 and 332: [153] T. Fujiwara, M. Bandi, M. Nit
- Page 333: [192] M. Hernandez, M. Nieto, and M
- Page 337 and 338: [268] H. Lemjabbar-Alaoui, A. van Z
- Page 339 and 340: [305] K. MAEDA, S. MATSUHASHI, K. T
- Page 341 and 342: [342] H. Moon, M. Ahn, J. Park, K.
- Page 343 and 344: [379] D. Park and J. Rich. Biology
- Page 345 and 346: [417] P. Rakic. Guidance of neurons
- Page 347 and 348: [456] T. Shima, N. Okumura, T. Taka
- Page 349 and 350: [490] P. A. C. t’Hoen, Y. Ariyure
- Page 351 and 352: [523] T. Watanabe, A. Takeda, T. Ts